Back to Agenda
Arnold Ventures Innovation Theater: Biosimilars Today - Who is Winning the Global Race?
Session Chair(s)
Representative Invited
United States
The global biosimilars market is growing rapidly. Today, there are over 50 biosimilars approved in the U.S. and over 120 biosimilars approved in Europe. However, only about 10% of the over 100 biologics expected to lose market exclusivity in the next decade have a biosimilar currently under development. This session will examine the different landscapes of biosimilar regulation and uptake in the global market today, focusing on a comparative analysis between the Europe and the United States.
Speaker(s)
Speaker
Mariana Socal, MD, PhD, MS
Johns Hopkins Bloomberg School of Public Health, United States
Associate Professor
Speaker
Gillian Woollett, PhD, MA
Samsung Bioepis, United States
Vice President, Head Regulatory Strategy and Policy
Have an account?